Feb 1, 2026 by Reuben Gregg Brewer3 Questions Investors Should Answer Before Buying Beyond Meat StockBeyond Meat was a market darling when it first went public, but you'll want to tread cautiously if you are looking to buy it today.
Feb 1, 2026 by Matt DiLalloThis Nearly 4%-Yielding Energy Stock Delivered Powerful Growth in 2025 With More to Come in 2026 and BeyondBrookfield Renewable has high-powered total return potential.
Feb 1, 2026 by Prosper Junior Bakiny1 Underrated Reason Netflix's Growth Story Isn't OverThe streaming giant's stock is trading at much lower levels than it was a year ago.
Feb 1, 2026 by Adé HennisScholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026The Chief Scientific Officer of Scholar Rock Holding Corp has made multiple filings regarding disposals in January 2026, but this should not alarm investors.
Feb 1, 2026 by Reuben Gregg Brewer3 Questions Investors Should Answer Before Buying Beyond Meat StockBeyond Meat was a market darling when it first went public, but you'll want to tread cautiously if you are looking to buy it today.
Feb 1, 2026 by Adé HennisLarge Biotech Fund Sells Shares of Cogent Biosciences for Over $120MA large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual performance ever in 2025.
Feb 1, 2026 by James HiresShould You Buy Nio Stock While It's Below $5 a Share?Nio is an innovative auto company operating in the world's largest auto market, but I'm still bearish on it.
Feb 1, 2026 by Matt DiLalloThis Nearly 4%-Yielding Energy Stock Delivered Powerful Growth in 2025 With More to Come in 2026 and BeyondBrookfield Renewable has high-powered total return potential.
Feb 1, 2026 by Adé HennisEnliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500kThe Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.
Feb 1, 2026 by Adé HennisProtagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover TaxesThe chief medical officer at one of the top pharmaceutical companies sold nearly 10,000 shares in late January 2026, but the reason was for something very simple.
Feb 1, 2026 by Prosper Junior Bakiny1 Underrated Reason Netflix's Growth Story Isn't OverThe streaming giant's stock is trading at much lower levels than it was a year ago.
Feb 1, 2026 by Keithen Drury3 AI Stocks to Buy in 2026 and Hold ForeverAI will have a lasting effect on the market.
Jan 31, 2026 by Adé HennisAmylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 MillionA Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock performance. But the sale is not what it seems.
Jan 31, 2026 by Jennifer SaibilCostco Stock Is Soaring. Is It Too Late to Buy?The market is embracing the retail king again.
Jan 31, 2026 by Jeremy BowmanThe AI Bubble Narrative Just Got Flipped On Its Head. Here's What Investors Need To Know.According to the latest movement, AI could be more disruptive than we thought.
Jan 31, 2026 by Maurie Backman4 Ways to Set Your 401(k) Up for Success in 2026With the right strategy, you can grow your savings nicely this year.
Jan 31, 2026 by Robert IzquierdoInvestment Firm Bouvel Raised Its Stake in This ETF by $8 Million. Is It a Buy?This actively managed fixed income ETF targets diversified bond exposure and reported a 5.09% annualized yield in its latest filing.
Jan 31, 2026 by Harsh ChauhanForget BigBear.ai: This Mission‑Critical AI Platform With Exploding Commercial Revenue Is the Better Long‑Term BetAn overreliance on government contracts is turning out to be a headwind for BigBear.ai.
Jan 31, 2026 by Adé HennisHarmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026.
Jan 31, 2026 by Daniel Foelber2 Financial Stocks Poised for a Comeback in 2026The sell-off in Mastercard and Visa is a tremendous buying opportunity for long-term investors.
Jan 31, 2026 by Daniel Miller2 High-Flying Electric Vehicle Stocks Have Serious Momentum -- But Are They Buys?These two EV stocks are hot topics in the automotive industry, but only one is a buy for risk-tolerant investors.
Jan 31, 2026 by Adé HennisArcellx Director Sells 6,000 Shares for $450,000A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid the company's stock having an underwhelming performance in 2025.
Jan 31, 2026 by Robert IzquierdoIs This Fixed Income ETF a Buy After Symmetry Partners Initiated a Large Position Valued at Nearly $134 Million?The Dimensional Global Core Plus Fixed Income ETF offers access to global bonds spanning government, corporate, and securitized markets.
